Compare FOLD & GHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOLD | GHC |
|---|---|---|
| Founded | 2002 | 1877 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.9B |
| IPO Year | 2006 | 1994 |
| Metric | FOLD | GHC |
|---|---|---|
| Price | $14.49 | $1,084.00 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $27.25 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 13.3K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 0.65% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ 66.47 |
| Revenue | N/A | ★ $2,932,099,000.00 |
| Revenue This Year | $20.50 | $7.73 |
| Revenue Next Year | $18.59 | $4.37 |
| P/E Ratio | ★ N/A | $16.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.66 | $882.21 |
| 52 Week High | $14.50 | $1,224.76 |
| Indicator | FOLD | GHC |
|---|---|---|
| Relative Strength Index (RSI) | 74.18 | 37.60 |
| Support Level | $14.21 | $1,026.24 |
| Resistance Level | N/A | $1,111.93 |
| Average True Range (ATR) | 0.02 | 31.67 |
| MACD | -0.00 | -6.79 |
| Stochastic Oscillator | 100.00 | 0.00 |
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Graham Holdings Company is a diversified holding company with operations spanning educational services, television broadcasting, healthcare, manufacturing, automotive dealerships, and other businesses. The Company's education activities are conducted through Kaplan, whose services include academic preparation programs for international students, English-language programs, exam preparation, and career and academic advisement. These services are provided to students, schools, and colleges, both domestically and outside the United States. It operates through seven reportable segments: Kaplan International, Kaplan Higher Education, Kaplan Supplemental Education, Television Broadcasting, CSI, Manufacturing and Automotive, with key revenue coming from the Education and Automotive segments.